CD44‐Targeted Antibody‐Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell‐Associated Molecular Programs
- DOI
- 10.1002/adhm.71897
- Published
- 2026-10-26
- Container
- Advanced Healthcare Materials
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.71897,
title = {CD44‐Targeted Antibody‐Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell‐Associated Molecular Programs},
author = {Prabhat Shrestha and Anil Giri and Thu‐Huyen Le Thi and Trung Huy Ngo and Sang Gyun Kim and Yulim Shin and Seungbin Park and Ananda Lamichhane and Sagar KC and Seungchan Yoo and Joo‐Won Nam and Jong‐Sun Kang and Jeong‐Won Lee and Yu Seok Youn and Sang Jeon Chung and Jee‐Heon Jeong and Simmyung Yook},
year = {2026},
journal = {Advanced Healthcare Materials},
doi = {10.1002/adhm.71897},
url = {https://doi.org/10.1002/adhm.71897}
}RIS
TY - JOUR TI - CD44‐Targeted Antibody‐Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell‐Associated Molecular Programs AU - Prabhat Shrestha AU - Anil Giri AU - Thu‐Huyen Le Thi AU - Trung Huy Ngo AU - Sang Gyun Kim AU - Yulim Shin AU - Seungbin Park AU - Ananda Lamichhane AU - Sagar KC AU - Seungchan Yoo AU - Joo‐Won Nam AU - Jong‐Sun Kang AU - Jeong‐Won Lee AU - Yu Seok Youn AU - Sang Jeon Chung AU - Jee‐Heon Jeong AU - Simmyung Yook PY - 2026 JO - Advanced Healthcare Materials DO - 10.1002/adhm.71897 UR - https://doi.org/10.1002/adhm.71897 ER -
APA
Shrestha, P., Giri, A., Thi, T. L., Ngo, T. H., Kim, S. G., Shin, Y., Park, S., Lamichhane, A., KC, S., Yoo, S., Nam, J., Kang, J., Lee, J., Youn, Y. S., Chung, S. J., Jeong, J., & Yook, S. (2026). CD44‐Targeted Antibody‐Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell‐Associated Molecular Programs. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71897
Source records
- crossref · retrieved 2026-11-10T06:11:51.762Z